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This Editorial is divided into two parts. 1. A summary of what 
is under the Bioinformation  aegis; 2. An example of a highly 
networked gene, NF-kB.  
 
The Bioinformation Aegis: 
Bioinformation (Online ISSN 0973-2063; Print ISSN 0973-8894) 
is a peer-reviewed journal that grows in leaps and bounds as 
the global scientific endeavor advances. Bioinformation publishes 
original biological research that utilizes mathematical and 
computational analysis. The fields in such analyses range from 
biochemistry and cell biology to genetics, epigenetics, systems 
biology, and brain imaging, from agriculture to tissue 
engineering and transplantation, from nanotechnology to 
evolution, and from basic research to clinical medicine, 
infectious disease, immunology, molecular structure, molecular 
therapy, and vaccines. This work is further often analyzed from 
the vantage point of data cleaning, analysis, representation, 
storage, retrieval, and knowledge extraction. Developing 
databases, datasets, prediction models, and computer programs 
fall under the purview of Bioinformation as well. Research 
articles published in Bioinformation demonstrate novelty, 
relevance, and coherence.   
 
Global scientific advances are accelerating, research and clinical 
studies are expanding, topics of study are increasing, as are 
publications, journals, and books. E-publishing has participated 
in this intellectual revolution, and has widened the already 
expanding scope and reach. Moreover, novel fields increase 
contemporaneously, e.g. nanotechnology and nanomedicine, 
imaging and genetics, vaccines for cancer, microorganisms (e.g. 
bacteria and parasites), and viruses (e.g. HIV, HCV, HBV, and 
arboviruses), as well as genetic engineering. Genetic 
engineering in agriculture is ubiquitous; genetic engineering in 
humans and animals is in progress. All this work requires 
concomitant development of fields including bioinformatics 
and modes of analysis. It is among the goals of Bioinformation to 
continue to promote and be the venue of all these advances and 
improvements.  
 
 
Figure 1: NF-kB interactions. In this figure, interactions - line-
color are Regulation- beige, Co-expression - purple and Physical 
interaction-brown. (GenePro SA Biosciences, BIOINFORMATION  open access 
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NF-kB, a highly networked gene: 
The example selected for this Editorial is the gene, NF-kB 
(Nuclear Factor kappa-light-chain-enhancer of activated B cells). 
NF-kB is a central gene that is expressed in eukaryotic cells. It is 
a transcription factor and interacts with the promoters and gene 
products of many gene pathways. Thus, it is central in gene 
control and expression and is highly utilized throughout 
eukaryotic evolution. It is important, for example, for treatment 
of cancer and due to its function in immunology. It is also 
involved in the control of expression of many mammalian 
viruses. More than 12 years ago, a list was published of some 
114 genes with which NF-kB interacts. Please see Table 1 (see 
supplementary material). A current view extends the 
interactions of NF-kB including 99 genes as indicated in (Figure 
1).  
Table 1 (see supplementary material) lists descriptions and 
functions of genes in that table. As noted in the (Figure 1) 
legend, interactions of NF-kB are indicated that involve 
regulation, co-expression, and actual physical interaction. 
Molecular processes in this figure include apoptosis, 
immunology, transcription, chromatin, and regulation of the 
NF-kB gene itself. Additional interactions are not shown 
because of the excessive overlapping information that would 
result in the figure. These include down-regulation, up-
regulation, predicted protein interaction, and predicted 
transcription factor interactions. Similarly, only 100 genes are 
shown since more than that would make the figure illegible. 
 
In summary then, this journal, Bioinformation, has a wide array 
of bioinformatics in its purview. This Editorial provides a 
simple scenario of the complexity of molecular information 
available, already in the literature, even for a single molecule.
Citation: Paul Shapshak, Bioinformation 8(9): 399-402 (2012) 
License statement: This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, 
for non-commercial purposes, provided the original author and source are credited 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 BIOINFORMATION  open access 
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 8(9):399-402 (2012)  401   © 2012 Biomedical Informatics
 
Supplementary material: 
 
Table 1: NF-kB interactions, http://www.panomics.com/NFkBhuman.html 
Sl. no  Abbreviations  Description 
1  a1 acid GP  Human alpha-1 acid glycoprotein mRNA, complete cds. 
2  A1AT  Human alpha-1-antitrypsin mRNA, complete cds. 
3  A20  Human tumor necrosis factor alpha inducible protein A20 mRNA, complete cds. 
4  ACTB  Homo sapiens actin, beta (ACTB), mRNA. 
5  ADORA1  Homo sapiens A1 adenosine receptor mRNA, complete cds. 
6  AGER  Homo sapiens advanced glycosylation end product-specific receptor (AGER), mRNA. 
7  AGT  Human angiotensinogen mRNA, complete CDS. 
8  AhRR  Homo sapiens dioxin receptor repressor (AHRR), mRNA. 
9  ALOX12  Human cell 12-lipoxygenase mRNA, complete cds. 
10  APOC3  Homo sapiens apolipoprotein C-III (APOC3), mRNA. 
11  BCL2A1  Homo sapiens BCL2-related protein A1 (BCL2A1), mRNA. 
12  BCL-xl  H. sapiens bcl-xL mRNA. 
13  BDKRB1  Homo sapiens bradykinin receptor B1 (BDKRB1), mRNA. 
14  BGN  Homo sapiens biglycan (BGN), mRNA. 
15  BLR1  Homo sapiens BLR1 gene for Burkitt's lymphoma receptor 1. 
16  CCND3  Human D3-type cyclin (CCND3) mRNA, complete cds. 
17  CCR5  Human CC chemokine receptor 5 mRNA, complete cds. 
18  CD23  Homo sapiens Fc fragment of IgE, low affinity II, receptor for (CD23A) (FCER2), mRNA. 
19  CD48  Human pan-leukocyte antigen (CD48) mRNA, complete cds. 
20  CD62  Homo sapiens selectin P (granule membrane protein 140kD, antigen CD62) (SELP), mRNA. 
21  CD69  Homo sapiens early activation antigen CD69 mRNA, complete cds. 
22  CD80  Homo sapiens CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) (CD80), mRNA. 
23  CD95   MRNA for Fas (Apo-1, CD95). 
24  c-myb  Homo sapiens v-myb myeloblastosis viral oncogene homolog (avian) (MYB), mRNA. 
25  c-myc  Homo sapiens v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA. 
26  COX-2  Homo sapiens cyclooxygenase-2 (Cox-2) mRNA, complete cds. 
27  c-rel  Homo sapiens v-rel avian reticulo-endotheliosis viral oncogene homolog (REL), mRNA. 
28 CSF-1  Human  macrophage-specific colony-stimulating factor (CSF-1) mRNA, complete cds. 
29  CSF2  Homo sapiens colony stimulating factor 2 (granulocyte-macrophage) (CSF2), mRNA. 
30  CSF3  Homo sapiens colony stimulating factor 3 (granulocyte) (CSF3), mRNA. 
31  CYC-D1  Human cyclin D (cyclin D1) mRNA, complete cds. 
32  DDH1  Human dihydrodiol dehydrogenase mRNA, complete cds. 
33  ELAM-1  Human endothelial leukocyte adhesion molecule 1 (ELAM-1) mRNA, complete cds. 
34  F8  Human coagulation factor VIII: C mRNA, complete cds. 
35  Fas-L  Human mRNA for Fas ligand, complete cds. 
36  FB  Human complement factor B mRNA, complete cds. 
37  FTH  Human ferritin H chain mRNA, complete cds. 
38  GAD65  Human glutamate decarboxylase (GAD65) mRNA, complete cds. 
39  Gal1-R  Homo sapiens galanin receptor (Gal1-R) mRNA, complete cds. 
40  GAL-3  Homo sapiens mRNA for galectin-3, complete cds. 
41  GAPDH  Homo sapiens glyceraldehyde-3-phosphate dehydrogenase (GAPD), mRNA. 
42  GRO1  Homo sapiens GRO1 oncogene (melanoma growth stimulating activity, alpha) (GRO1), mRNA. 
43  GSTP1  Homo sapiens glutathione S-transferase pi (GSTP1), mRNA. 
44  HAS1  Human hyaluronan synthase mRNA, complete cds. 
45  HLA-G1  Human lymphocyte antigen (HLA-G1) mRNA, complete cds. 
46  HMG-14  Human non-histone chromosomal protein HMG-14 mRNA, complete cds. 
47  HMOX1  Homo sapiens heme oxygenase (decycling) 1 (HMOX1), mRNA. 
48  ICAM-1  Human intercellular adhesion molecule-1 (ICAM-1) mRNA, complete cds. 
49  IFNb  Human interferon-beta mRNA, complete cds. 
50  IFNg  Human immune interferon (IFN-gamma) gene, complete cds. 
51  IGFBP1  Homo sapiens insulin-like growth factor binding protein 1 (IGFBP1), mRNA. 
52  IGFBP-2  Human mRNA for insulin-like growth factor binding protein (IGFBP-2). 
53  IL10  Human interleukin 10 (IL10) gene, complete cds. 
54  IL11  Human interleukin 11 mRNA, complete cds. 
55  IL12  Homo sapiens interleukin 12, P40 mRNA, complete cds. 
56  IL15  Homo sapiens interleukin 15 precursor (IL-15) mRNA, complete cds. 
57  IL1-a  Human gene for interleukin 1 alpha (IL-1 alpha). 
58  IL1b  Human interleukin 1-beta (IL1B) mRNA, complete cds. 
59  IL1RN  Homo sapiens interleukin 1 receptor antagonist (IL1RN), mRNA. 
60  IL2  Human interleukin 2 (IL2) mRNA, complete cds. 
61  IL2-Ra  Human interleukin-2 receptor mRNA (short form), complete cds. 
62  IL6  Human interleukin 6 mRNA, complete cds. 
63  IL8  Human interleukin 8 (IL8) gene, complete cds. 
64  IL9  Human IL9 protein gene, complete cds. BIOINFORMATION  open access 
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65  IRF1  Homo sapiens interferon regulatory factor 1 (IRF1), mRNA. 
66  IRF-2  Human mRNA for interferon regulatory factor-2 (IRF-2). 
67  JUN-B  Human jun-B mRNA for JUN-B protein. 
68  LAMB2  LAMB2 mRNA for beta2 laminin. 
69  LMP-2  Human proteasome-related (LMP-2) mRNA, complete cds. 
70  Lox-1  Homo sapiens oxidized low-density lipoprotein receptor mRNA, complete cds. 
71  LYZ  Homo sapiens lysozyme (renal amyloidosis) (LYZ), mRNA. 
72  MAD-3  Homo sapiens MAD-3 mRNA encoding IkB-like activity, complete cds. 
73  MAdCAM-1  Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) mRNA, complete cds. 
74  MCP-1  mRNA for monocyte chemoattractant protein 1 (MCP-1). 
75  MDR-1  Homo sapiens P-glycoprotein (mdr1) mRNA, complete cds. 
76  MIP-2g  Homo sapiens chemokine MIP-2 gamma (MIP-2 gamma) mRNA, complete cds. 
77  MMP1  Homo sapiens matrix metalloproteinase 1 (interstitial collagenase) (MMP1), mRNA. 
78 MMP-3  Human  matrix  metalloproteinase-3 (MMP-3) mRNA, complete cds. 
79  MMP9  Homo sapiens matrix metalloproteinase 9 (gelatinase B, 92kD gelatinase, 92kD type IV collagenase) (MMP9), 
mRNA. 
80  Mn-SOD  Human mRNA for mangano-superoxide dismutase (Mn-SOD). 
81  MSX1  Homo sapiens msh homeo box homolog 1 (Drosophila) (MSX1), mRNA. 
82  MTS1  MTS1=multiple tumor suppressor 1/cyclin-dependent kinase 4 inhibitor p16 (cosmid c5 region, exon 2) 
[human, melanoma cell line, Genomic Mutant, 457 nt]. 
83  NFKB1  Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) (NFKB1), mRNA. 
84  NFKB2  Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), 
mRNA. 
85  NOS  Human inducible nitric oxide synthase (NOS) mRNA, complete cds. 
86  NPYY1  Human neuropeptide Y receptor Y1 (NPYY1) mRNA, exon 2-3 and complete cds. 
87  p53  Human p53 cellular tumor antigen mRNA, complete cds. 
88  PAFR1  Homo sapiens mRNA for platelet-activating factor receptor, complete cds. 
89  PAX8  Human paired box homeotic protein (PAX8) mRNA, complete cds. 
90  PDGF-B  Human mRNA for platelet-derived growth factor B chain (PDGF-B). 
91  PENK  Homo sapiens proenkephalin (PENK), mRNA. 
92 PRG1  PRG1  gene. 
93  PTGIS  Human mRNA for prostacyclin synthase, complete cds. 
94  PTX3  Homo sapiens pentaxin-related gene, rapidly induced by IL-1 beta (PTX3), mRNA. 
95  RANTES  Human T cell-specific protein (RANTES) mRNA, complete cds. 
96  SAA  Human serum amyloid A gene, complete cds. 
97  SCYA11  Human eotaxin precursor mRNA, complete cds. 
98  SCYB11  Homo sapiens small inducible cytokine subfamily B (Cys-X-Cys), member 11 (SCYB11), mRNA. 
99  TAP1  Homo sapiens peptide transporter (TAP1) mRNA, complete cds. 
100  TCRB  Human T-cell receptor active beta-chain (DJC-region) mRNA from Jurkat cell line (clone JUR-beta-2). 
.  101  TGM1  Homo sapiens trans-glutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyl-
transferase) (TGM1), mRNA. 
.  102  THBS2  Human thrombospondin 2 (THBS2) mRNA, complete cds. 
.  103  TNC   mRNA for tenascin-C, 7560bp. 
.  104  TNF  Human mRNA for tumor necrosis factor. 
.  105  TNFb  Human mRNA for lymphotoxin (TNF-beta), complete cds. 
.  106  TNF-R  TNF-R mRNA for tumor necrosis factor receptor type 1. 
.  107  TNSFS5  Homo sapiens tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) (TNFSF5), 
mRNA. 
.  108  UBC  Homo sapiens ubiquitin C (UBC), mRNA. 
.  109  UGT8  Homo sapiens UDP glycosyl-transferase 8 (UDP-galactose ceramide galactosyl-transferase) (UGT8), mRNA. 
.  110  UPAR  Human urokinase-type plasminogen activator receptor mRNA, complete cds. 
.  111  VCAM-1  Human mRNA for vascular cell adhesion molecule 1 (VCAM-1). 
.  112  VEGFC  Homo sapiens vascular endothelial growth factor C (VEGFC), mRNA. 
.  113  VIM  Human vimentin gene, complete cds. 
.  114  WT1  Homo sapiens Wilms tumor 1 (WT1), mRNA. 
 